Candidate antiretroviral agents for use in postexposure prophylaxis.
Saag
M S
MS
Department of Medicine, The University of Alabama at Birmingham, 35294-2050, USA.
D019380:Anti-HIV Agents / Q000009:adverse effects / Q000494:pharmacology*; D004279:DNA, Viral / Q000187:drug effects; D015507:Drugs, Investigational / Q000494:pharmacology*; D015658:HIV Infections / Q000209:etiology / Q000517:prevention & control*; D017320:HIV Protease Inhibitors / Q000494:pharmacology; D015497:HIV-1 / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics; D006282:Health Personnel; D006801:Humans; D016273:Occupational Exposure / Q000009:adverse effects*; D012367:RNA, Viral / Q000187:drug effects; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology
D019380:Anti-HIV Agents; D004279:DNA, Viral; D015507:Drugs, Investigational; D017320:HIV Protease Inhibitors; D012367:RNA, Viral; D018894:Reverse Transcriptase Inhibitors